Supplementary Tables from Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer
Alison O. Cudmore, Barbara C. Vanderhyden(University of Ottawa)
Cited by 0
Related Papers
GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
|Oncogene|2018|88
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
|Communications Biology|2023|29
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
|Journal of Ovarian Research|2023|22
PAX2 induces vascular‑like structures in normal ovarian cells and ovarian cancer
|Experimental and Therapeutic Medicine|2022|8